ARTICLE | Clinical News
MGI regulatory update
July 22, 1996 7:00 AM UTC
MOGN's Salagen Tablets received approval in Israel to treat the symptoms of xerostomia (dry mouth) caused by radiation therapy for cancer of the neck and head, and for the symptoms of Sjögren's Syndrome, an autoimmune disease. ...